Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1729–1752 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Opioid Use Disorder
Interventions: Not listed
Lead sponsor: Tools4Patient; Other
Eligibility: 18 Years and older
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 2
States / cities: San Diego, California • Vista, California

Conditions: Alcohol Use Disorder (AUD)
Interventions: SIM-AiR; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 12 Years to 19 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease
Interventions: Fecal Microbiota Transplant; Combination Product
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Ventura, California

Conditions: Carotid Artery Calcification, Carotid Artery Diseases
Interventions: Carotid Intravascular Lithotripsy; Device
Lead sponsor: Shockwave Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 25
States / cities: Scottsdale, Arizona • Aurora, Colorado • Jacksonville, Florida + 19 more

Conditions: Gastrointestinal Neoplasms, Genitourinary Cancer, Thoracic Cancer, Sarcoma, Melanoma
Interventions: ICI Therapy; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Knee Injury, ACL Injury, Meniscus Tear, Hispanic or Latino, Adolescent
Interventions: Educational program and patient navigator; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 14 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coccidioidomycosis, Blastomycosis, Histoplasmosis, Dimorphic Fungal Infection, Endemic Mycoses
Interventions: Oteseconazole; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: Phoenix, Arizona • Tempe, Arizona • Davis, California + 1 more

Conditions: Bariatric Surgery Candidate
Interventions: Xpan Trocar System, Standard of Care (Non-expanding Trocar); Device
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Lactation
Interventions: Zoliflodacin; Drug
Lead sponsor: Global Antibiotics Research and Development Partnership; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Chronic Stroke
Interventions: Virtual reality based dance group, Active Comparator: Control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: AL Amyloidosis
Interventions: Anselamimab; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Intraocular Pressure (IOP), Healthy Adult
Interventions: Eplerenone, Microcrystalline Cellulose NF (placebo); Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Axial Spondyloarthritis (AxSpA)
Interventions: Secukinumab (IL-17i ), Upadacitinib (JAKi); Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: AI Companionship
Interventions: AI Companion Interaction; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Nemaline Myopathy
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 0 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 5
States / cities: Palo Alto, California • Bethesda, Maryland • Boston, Massachusetts + 2 more

Conditions: Amyotrophic Lateral Sclerosis, Cytochrome P-450 Enzyme System
Interventions: LY3873862, CYP450 Drug Cocktail, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: San Francisco, California • Aurora, Colorado • Washington D.C., District of Columbia + 2 more

Conditions: Contracted Bladder
Interventions: "Neo-Bladder" Construct; Biological
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Genetics in Hypertension
Interventions: low sodium diet, high sodium diet, renal plasma flow, SIEA collection; Other · Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gulf War Syndrome
Interventions: Placebo, Pycnogenol, 100mg, Pycnogenol, 200mg, Pycnogenol, 400mg, Pycnogenol, 600mg; Other · Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Chronic Hypertension in Pregnancy
Interventions: Remote Patient Monitoring; Procedure
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Chronic Low Back Pain, Musculoskeletal Pain
Interventions: intermittent theta burst stimulation, LoveYourBrain Yoga Program; Device · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 22 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Chicago, Illinois • Hines, Illinois

Conditions: Hearing Disability, Depression, Mobility Disability
Interventions: Sham Digital Program - General health education and interactive quizzes unrelated to depression or CBT., Toivoa-002 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching.; Device
Lead sponsor: Toivoa Inc; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Dover, Delaware • East Orange, New Jersey • Cleveland, Ohio + 1 more

Conditions: Posttraumatic Stress Disorder, Metabolic Syndrome, Insulin Resistance
Interventions: prazosin; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Posterior Spinal Fusion, Idiopathic Scoliosis, Neuromuscular Scoliosis
Interventions: Serum blood samples for serum biomarkers of immune response; Diagnostic Test
Lead sponsor: Ambrish Patel; Other
Eligibility: 0 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment

Social Identity Mapping for Adolescent Recovery

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE [Investigational Device Exemption] Study)

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

Reducing Disparities in Knee Arthroscopy for Adolescents

Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi

Xpan Non-Inferiority Study

Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating Women

Active Balance and Cardio Care Intervention on Physical and Cardiovascular Health in People With Chronic Stroke

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Eplerenone and IOP in Healthy Adults

A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis

How Do Artificially Intelligent Companions Influence Psychological Outcomes?

Nemaline Myopathy Clinical Research Network (NM-CTRN)

A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).

Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct

Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness

Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)

Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT

Reduction of Depression Through Dual Treatment: Digital CBT & NBHWC Coaching

Assessing Trauma-related Links Between Affective and Metabolic Systems

Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis